Nautilus Biotechnology NAUT Stock
Nautilus Biotechnology Price Chart
Nautilus Biotechnology NAUT Financial and Trading Overview
| Nautilus Biotechnology stock price | 2.32 USD |
| Previous Close | 2.38 USD |
| Open | 2.38 USD |
| Bid | 1.69 USD x 200 |
| Ask | 2.85 USD x 200 |
| Day's Range | 2.21 - 2.4 USD |
| 52 Week Range | 0.84 - 4.31 USD |
| Volume | 1.87M USD |
| Avg. Volume | 5.95M USD |
| Market Cap | 295.5M USD |
| Beta (5Y Monthly) | 0.655 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.46 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4 USD |
NAUT Valuation Measures
| Enterprise Value | 235.67M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.135135 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 696.9434 |
| Price/Book (mrq) | 2.535519 |
| Enterprise Value/Revenue | 555.823 |
| Enterprise Value/EBITDA | -3.755 |
Trading Information
Nautilus Biotechnology Stock Price History
| Beta (5Y Monthly) | 0.655 |
| 52-Week Change | 22.10% |
| S&P500 52-Week Change | 13.32% |
| 52 Week High | 4.31 USD |
| 52 Week Low | 0.84 USD |
| 50-Day Moving Average | 1.87 USD |
| 200-Day Moving Average | 2.13 USD |
NAUT Share Statistics
| Avg. Volume (3 month) | 5.95M USD |
| Avg. Daily Volume (10-Days) | 4.7M USD |
| Shares Outstanding | 127.37M |
| Float | 79.22M |
| Short Ratio | 0.48 |
| % Held by Insiders | 32.01% |
| % Held by Institutions | 39.46% |
| Shares Short | 5.84M |
| Short % of Float | 9.31% |
| Short % of Shares Outstanding | 4.58% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -15105.65% |
| Gross Margin | 90.80% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.88% |
| Return on Equity (ttm) | -41.0099% |
Income Statement
| Revenue (ttm) | 424K USD |
| Revenue Per Share (ttm) | 0.003 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 385K USD |
| EBITDA | -62759000 USD |
| Net Income Avi to Common (ttm) | -58583000 USD |
| Diluted EPS (ttm) | -0.46 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 86.58M USD |
| Total Cash Per Share (mrq) | 0.68 USD |
| Total Debt (mrq) | 26.74M USD |
| Total Debt/Equity (mrq) | 22.94 USD |
| Current Ratio (mrq) | 9.247 |
| Book Value Per Share (mrq) | 0.915 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -52482000 USD |
| Levered Free Cash Flow (ttm) | -31660000 USD |
Profile of Nautilus Biotechnology
| Country | United States |
| State | WA |
| City | Seattle |
| Address | 2701 Eastlake Avenue East |
| ZIP | 98102 |
| Phone | 206 333 2001 |
| Website | https://www.nautilus.bio |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 128 |
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
Q&A For Nautilus Biotechnology Stock
What is a current NAUT stock price?
Nautilus Biotechnology NAUT stock price today per share is 2.32 USD.
How to purchase Nautilus Biotechnology stock?
You can buy NAUT shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nautilus Biotechnology?
The stock symbol or ticker of Nautilus Biotechnology is NAUT.
Which industry does the Nautilus Biotechnology company belong to?
The Nautilus Biotechnology industry is Biotechnology.
How many shares does Nautilus Biotechnology have in circulation?
The max supply of Nautilus Biotechnology shares is 127.37M.
What is Nautilus Biotechnology Price to Earnings Ratio (PE Ratio)?
Nautilus Biotechnology PE Ratio is now.
What was Nautilus Biotechnology earnings per share over the trailing 12 months (TTM)?
Nautilus Biotechnology EPS is -0.46 USD over the trailing 12 months.
Which sector does the Nautilus Biotechnology company belong to?
The Nautilus Biotechnology sector is Healthcare.
Nautilus Biotechnology NAUT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
25136.27 USD — |
-0.91
|
7.74B USD — | 24872.41 USD — | 25423.09 USD — | — - | 7.74B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12378.66 USD — |
-0.9
|
— — | 12248.6 USD — | 12520.36 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7211.27 USD — |
-0.5
|
— — | 7149.19 USD — | 7238.9 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1368.29 USD — |
-0.34
|
— — | 1358.68 USD — | 1373.65 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
